Publications by authors named "Jan Buckner"

Claim this Profile
C
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.
Evanthia Galanis, Katharine E Dooley, S Keith Anderson, Cheyne B Kurokawa, Xiomara W Carrero, Jan C Buckner

Nat Commun· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.
Joshua D Palmer, Brett G Klamer, Karla V Ballman, Paul D Brown, Jane H Cerhan, Jan C Buckner

JAMA Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology.
Rahma Warsame, Joselle Cook, Briant Fruth, Joleen Hubbard, Katrina Croghan, Jan Buckner

Contemp Clin Trials Commun· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma.
Ian F Parney, S Keith Anderson, Michael P Gustafson, Susan Steinmetz, Timothy E Peterson, Jan C Buckner

Neurooncol Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).
Evanthia Galanis, S Keith Anderson, Erin Twohy, Nicholas A Butowski, Adilia Hormigo, Jan C Buckner

Neurooncol Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD).
Jon C Tilburt, David Zahrieh, Joel E Pacyna, Daniel G Petereit, Judith S Kaur, Jan C Buckner

Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologists' reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center.
Jeremiah Stout, Cambray Smith, Jan Buckner, Alex A Adjei, Mark Wentworth

PLoS One· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"I Think It's Been Met With a Shrug:" Oncologists' Views Toward and Experiences With Right-to-Try.
Cambray Smith, Jeremiah Stout, Alex A Adjei, Jan Buckner, Mark Wentworth

J Natl Cancer Inst· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.
Erica H Bell, Peixin Zhang, Edward G Shaw, Jan C Buckner, Geoffrey R Barger

J Clin Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma.
William G Breen, S Keith Anderson, Xiomara W Carrero, Paul D Brown, Karla V Ballman, Jan C Buckner

Neuro Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further understanding of glioma mechanisms of pathogenesis: implications for therapeutic development.
Michael Ruff, Sani Kizilbash, Jan Buckner

Expert Rev Anticancer Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arti Hurria, M.D.: A tribute to her shining legacy in the Alliance for Clinical Trials in Oncology.

J Geriatr Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3).
Daniel M Trifiletti, Karla V Ballman, Paul D Brown, S Keith Anderson, Xiomara W Carrero, Jan C Buckner

Int J Radiat Oncol Biol Phys· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.
Craig Horbinski, Keith L Ligon, Priscilla Brastianos, Jason T Huse, Monica Venere, Jan Buckner

Neuro Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872.
Evanthia Galanis, S Keith Anderson, Erin L Twohy, Xiomara W Carrero, Jesse G Dixon, Jan C Buckner

Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral blood volume and apparent diffusion coefficient - Valuable predictors of non-response to bevacizumab treatment in patients with recurrent glioblastoma.
Lucie Petrova, Panagiotis Korfiatis, Ondra Petr, Daniel H LaChance, Ian Parney, Jan C Buckner

J Neurol Sci· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary neuroendocrine carcinoma of the brain.
Clay T Reed, Narjust Duma, Thorvardur Halfdanarson, Jan Buckner

BMJ Case Rep· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
Kurt A Jaeckle, S K Anderson, Erin L Twohy, Jesse G Dixon, Caterina Giannini, Jan C Buckner

J Neurooncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
Kurt A Jaeckle, S K Anderson, Erin L Twohy, Jesse G Dixon, Caterina Giannini, Jan C Buckner

J Neurooncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of low-grade glioma: a systematic review and meta-analysis.
Timothy J Brown, Daniela A Bota, Martin J van Den Bent, Paul D Brown, Elizabeth Maher, Jan C Buckner

Neurooncol Pract· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversies in the Therapy of Low-Grade Gliomas.
Ivan D Carabenciov, Jan C Buckner

Curr Treat Options Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?
Martin C Tom, Daniel P Cahill, Jan C Buckner, Jörg Dietrich, Michael W Parsons

Am Soc Clin Oncol Educ Book· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuro-Oncology Clinical Debate: PCV or temozolomide in combination with radiation for newly diagnosed high-grade oligodendroglioma.
Michael W Ruff, Jan C Buckner, Derek R Johnson, Martin J van den Bent, Marjolein Geurts

Neurooncol Pract· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype.
Nooshi K Dashti, Rebecca N Wehrs, Brittany C Thomas, Asha Nair, Jaime Davila, Jan C Buckner

Histopathology· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD.
Joel E Pacyna, Simon Kim, Kathleen Yost, Hillary Sedlacek, Daniel Petereit, Jan Buckner

BMC Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis